Oxidative stress in type 1 diabetes: A clinical perspective

Nutrition and Diabetes: Pathophysiology and Management

Volumn , Issue , 2005, Pages 319-344

  Hoeldtke, Robert D ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 64349110040     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (103)

1. Abou-Seif, MA and Youssef, AA, Evaluation of some biochemical changes in diabetic patients, Clin. Chimica. Acta., 346:161-170, 2004.
2. Agarwal, R and Chase, SD, Rapid, fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples, J. Chromatogr., B775:121-126, 2002.
3. Akselrod, S, Gordon, D, Ubel, FA, Shannon, DC, Berger, AC, and Cohen, RJ, Power spectrum analysis of heart rate fluctuations: a quantitative probe of beat-to-beat cardiovascular control, Science, 213:220-222, 1981.
4. Ames, BN, Cathcart, R, Schwiers, E, and Hochstein, P, Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: A hypothesis, Proc. Natl. Acad. Sci., 78:6858-6862, 1981.
5. Asayama, K, Uchida, N, Nakane, T, Hayashibe, H, Dobashi, K, Amemiya, S, Kato, K, and Nakazawa, S, Antioxidants in the serum of children with insulin-dependent diabetes mellitus, Free Radic. Biol. Med., 15:597-602, 1993.
6. Astley, S, Langrish-Smith, A, Southon, S, and Sampson, M, Vitamin E supplementation and oxidative damage to DNA and plasma LDL in Type 1 diabetes, Diabet. Care, 22:1626-1631, 1999.
7. Bagi Z, Ungvari, Z, and Koller, A, Xanthine oxidase-derived reactive oxygen species convert flow-induced arteriolar dilation to constriction in hyperhomocysteinemia. Possible role of peroxynitrite, Arterioscler. Thromb. Vasc. Biol., 22:28-33, 2002.
8. Bank, N and Aynedjian, HS, Role of EDRF (nitric oxide) in diabetic renal hyperfiltration, Kidney Int., 43:1306-1312, 1993.
9. Banks, BA, Ischiropoulos, H, McClelland, M, Ballard, PL, and Ballard, RA, Plasma 3-nitrotyrosine is elevated in premature infants who develop broncholpulmonary dysplasia, Pediatrics, 101:870-874, 1998.
10. Bardell, AL and Macleod, KM, Evidence for inducible nitric-oxide synthase expression and activity in vascular smooth muscle of streptozotocin-diabetic rats, J. Pharmacol. Exper. Therap., 296:252-259, 2001.
11. Baynes, JW and Thorpe, SR, Role of oxidative stress in diabetic complications: a new perspective on an old paradigm, Diabetes, 48:1-9, 1999.
12. Beckman, JS and Koppenol, WH, Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly, Amer. J. Physiol., 271:C1424-C1437, 1996.
13. Beisswenger, PJ, Howell, SK, Nelson, RG, Mauer, M, and Szwergold, B, α-Oxoaldehyde metabolism and diabetic complications, Biochem. Soc. Trans., 31:1358-1363, 2003.
14. Benkusky, NA, Lewis, SJ, and Kooy, NW, Peroxynitrite-mediated attenuation of α-and β-adrenoceptor agonist-induced vascular responses in vivo, Eur. J. Pharmacol., 364:151-158, 1999.
15. Berg, TJ, Nourooz-Zadeh, J, Wolff, SP, Tritschler, HJ, Bangstad, HJ, and Hanssen, KF, Hydroperoxides in plasma are reduced by intensified insulin treatment, Diabet. Care, 21:1295-1300, 1998.
16. Bojunga, J, Dresar, B, Kusterer, K, Sterner-Kock, A, Konrad, T, and Usadel, KH, Tissue-specific expression of endothelial and inducible nitric oxide synthase and oxidative stress in streptozotocin-induced diabetic rats, Diabetes, 50(Suppl. 2):148, 2001.
17. Bottino, R, Balamurugan, AN, Bertera, S, Pietropaolo, M, Trucco, M, and Piganelli, JD, Preservation of human islet cell functional mass by anti-oxidative action of a novel SOD mimic compound, Diabetes, 51:2561-2567, 2002.
18. Bourajjaj, M, Stehouwer, CDA, van Hinsbergh, VWM, and Schalkwijk, CG, Role of methylglyoxal adducts in the development of vascular complications in diabetes mellitus, Biochem. Soc. Trans., a31:1400-1402, 2003.
19. Bravenboer, B, Kappelle, AC, Hamers, FP, van Buren, T, Erkelens, DW, and Gispen, WH, Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat, Diabetologia, 35:813-817, 1992.
20. Brennan, ML, Wu, W, Fu, X, Shen, ZZ, Song, W, Frost, H, Vadseth, C, Narine, L, Lenkiewicz, E, Borchers, MT, Lusis, AJ, Lee, JJ, Lee, NA, Abu-Soud, HM, Ischiropoulos, H, and Hazen, SL, A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species, J. Biol. Chem., 277:17415-17427, 2002.
21. Cameron, NE, Cotter, MA, Archibald, V, Dines, KC, and Maxfield, EK, Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats, Diabetologia, 37:449-459, 1994.
22. Cameron, NE, Cotter, MA, and Maxfield, EK, Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats, Diabetologia, 36:299-304, 1993.
23. Ceriello, A, Bortolotti, N, Falleti, E, Taboga, C, Tonutti, L, Crescentini, A, Motz, E, Lizzio, S, Russo, A, and Bartoli, E, Total radical-trapping antioxidant parameter in NIDDM patients, Diabet. Care, 20:194-197, 1997.
24. Ceriello, A, Mercuri, F, Quagliaro, L, Assaloni, R, Motz, E, Tonutti, L, and Taboga, C, Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress, Diabetologia, 44:834-838, 2001.
25. Ceriello, A, Morocutti, A, Mercuti, F, Quagliaro, L, Moro, M, Damante, G, and Viberti, GC, Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy, Diabetes, 49:2170-2177, 2000.
26. Chari, SN, Nath, N, and Rathi, AB, Glutathione and its redox system in diabetic polymorphonuclear leukocytes, Amer. J. Med. Sci., 287:14-15, 1984.
27. Chaudhuri, A, Vascular reactivity in diabetes mellitus, Curr. Diab. Rep., 2:305-310, 2002.
28. Chiarelli, F, Cipollone, F, Romano, F, Tumini, S, Costantini, F, di Ricco, L, Pomilio, M, Pierdomenico, SD, Marini, M, Cuccurullo, F, and Mezzetti, A, Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria, Diabetes, 49:1258-1263, 2002.
29. Coppey, LJ, Gellett, JS, Davidson, EP, Dunlap, JA, Lund, DD, and Yorek, MA, Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve, Diabetes, 50:1927-1937, 2001.
30. Cotter, MA and Cameron, NE, Neuroprotective effects of carvedilol in diabetic rats: Prevention of defective peripheral nerve perfusion and conduction velocity, Naunyn. Schmiedebergs. Arch. Pharmacol., 351:630-635, 1995.
31. Cotter, MA, Love, A, Watt, MJ, Cameron, NE, and Dines, KC, Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats, Diabetologia, 38:1285-1294, 1995.
32. Cowell, RM and Russell, JW, Nitrosative injury and antioxidant therapy in the management of diabetic neuropathy, J. Invest. Med., 52:33-44, 2004.
33. Cowie, CC and Kenny, D, Diabetes Control and Complications Trial data archives, Biostatistics Center at George Washington University, Washington DC (provided by NIDDK and the Diabetes Control and Complications Trial Research Group), 2001.
34. Dandona, P, Thusu, K, Cook, S, Snyder, B, Makowski, J, and Armstrong, D, Oxidative damage to DNA in diabetes mellitus, Lancet, 347:444-445, 1996.
35. Davi, G, Ciabattoni, G, Consoli, A, Mezzetti, A, Falco, A, Santarone, S, Pennese, E, Vitacolonna, E, Bucciarelli, T, Costantini, F, Capani, F, and Patrono, C, In vivo formation of 8-iso-prostaglandin F2 alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation, Circulation, 99:224-229, 1999.
36. Dincer, Y, Akcay, T, Ilkova, H, Alademir, Z, and Ozbay, G, DNA damage and antioxidant defense in peripheral leukocytes of patients with Type 1 diabetes mellitus, Mutat. Res., 527:49-55, 2003.
37. Eizirik, DL, Flodstrom, M, Karlsen, AE, and Welsh, N, The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells, Diabetologia, 39:875-890, 1996.
38. Ewing, DJ, Martyn, CN, Young, RJ, and Clarke, BF, The value of cardiovascular autonomic function tests: 10 years experience in diabetes, Diabet. Care, 8:491-498, 1985.
39. Feldman, E, Oxidative stress and diabetic neuropathy: a new understanding of an old problem, J. Clin. Invest., 111:431-433, 2003.
40. Flodstrom, M, Tyrberg, B, Eizirik, DL, and Sandler, S, Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes, Diabetes, 48:706-713, 1999.
41. Frost, MT, Halliwell, B, and Moore, KP, Analysis of free and protein-bound nitrotyrosine in human plasma by a gas chromatography/mass spectrometry method that avoids nitration artifacts, Biochem. J., 345:453-458, 2000.
42. Garcia, SB, Paula, JS, Giovannetti, GS, Zenha, F, Ramalho, EM, Zucoloto, S, Silva, JS, and Cunha, FQ, Nitric oxide is involved in the lesions of the peripheral autonomic neurons observed in the acute phase of experimental Trypanosoma cruzi infection, Exp. Parasitol., 93:191-197, 1999.
43. Guzel, S, Seven, A, Satman, I, and Burcak, G, Comparison of oxidative stress indicators in plasma of recent-onset and long-term Type 1 diabetic patients, J. Toxicol. Environ. Health, A59:7-14, 2000.
44. Hamdy, O and Abedlmoneim, M, Lipid peroxidation could be related to the initiation and/or evolution of diabetic peripheral neuropathy in type II diabetes, Diabetes, 44(Suppl.):225A, 1995.
45. Hatano, E, Bennett, BL, Manning, AM, Qian, T, Lemasters, JJ, and Brenner, DA, NF-κB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-α-and Fas-Mediated apoptosis, Gastroenterology, 120:1251-1262, 2001.
46. Hensley, K, Maidt, ML, Yu, Z, San, H, Merkesbery, WR, and Floyd, RA, Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation, J. Neuroscience, 18:8126-8132, 1998.
47. Hoeldtke, RD, unpublished observations.
48. Hoeldtke, RD, Bryner, KD, Hobbs, GR, Horvath, GG, Riggs, JE, Christie, I, Ganswer, G, Marcovina, SM, and Lernmark, A, Antibodies to glutamic acid decarboxylase and peripheral nerve function in type 1 diabetes, J. Clin. Endocrinol. Metab., 85:3297-3308, 2000.
49. Hoeldtke, RD, Bryner, KD, Horvath, GG, Phares, RW, Broy, LF, and Hobbs, GR, Redistribution of sudomotor responses is an early sign of sympathetic dysfunction in type 1 diabetes, Diabetes, 50:436-443, 2001.
50. Hoeldtke, RD, Bryner, KD, Komanduri, P, Christie, I, Ganser, G, and Hobbs, GR, Decreased prorenin processing develops before autonomic dysfunction in type 1 diabetes, J. Clin. Endo. Metab., 85:585-589, 2000.
51. Hoeldtke, RD, Bryner, KD, McNeill, DR, Hobbs, GR, Riggs, JE, Warehime, SS, Christie, I, Ganser, G, and Van Dyke, K, Nitrosative stress, uric acid, and peripheral nerve function in early type 1 diabetes, Diabetes, 51:2817-2825, 2002.
52. Hoeldtke, RD, Bryner, KD, McNeill, DR, Warehime, SS, Van Dyke, K, and Hobbs, G, Oxidative stress and insulin requirements in patients with recent-onset type 1 diabetes, J. Clin. Endocrinol. Metab., 88:1624-1628, 2003.
53. Hoeldtke, RD and Cilmi, KM, Norepinephrine secretion and production in diabetic autonomic neuropathy, J. Clin. Endocrinol. Metab., 59:246-252, 1984.
54. Ihara, Y, Toyokuni, S, Uchida, K, Odaka, H, Tanaka, T, Ikeda, H, Hiai, H, Seino, Y, and Yamada, Y, Hyperglycemia causes oxidative stress in pancreatic β-cells of GK rats, a model of type 2 diabetes, Diabetes, 48:927-932, 1999.
55. Ihara, Y, Yamada, Y, Toyokuni, S, Miyawaki, K, Ban, N, Adachi, T, Kuroe, A, Iwakura, T, Kubota, A, Hiai, H, and Scino, Y, Antioxidant α-tocopherol ameliorates glycemic control of GK rats, a model of type 2 diabetes, F.E.B.S. Lett., 473:24-26, 2000.
56. Jamal, GA, Hansen, S, Weir, AL, and Ballantyne, JP, The neurophysiologic investigation of small fiber neuropathies, Musc. Nerve, 10:537-545, 1987.
57. Janero, DR, Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury, Free Radic. Biol. Med., 9:515-540, 1990.
58. Kageyama, N, A direct colorometric determination of uric acid in serum and urine with uricase-catalase system, Clin. Chem. Acta., 31:421-426, 1971.
59. Kaneto, H, Fujii, J, Myint, T, Miyazawa, N, Islam, KN, Kawasaki, Y, Suzuki, K, Nakamura, M, Tatsumi, H, Yamasaki, Y, and Taniguchi, N, Reducing sugars trigger oxidative modification and apoptosis in pancreatic β-cells by provoking oxidative stress through the glycation reaction, Biochem. J., 320:855-863, 1996.
60. Kaneto, H, Kajimato, Y, Miyagawa, J, Matsuoka, T, Fujitani, Y, Umayahara, Y, Hanafusa, T, Matsuzawa, Y, Yamasaki, Y, and Hori, M, Beneficial effects of antioxidants in diabetes. Possible protection of pancreatic β-cells against glucose toxicity, Diabetes, 48:2398-2406, 1999.
61. Keaney, JF, Simon, DI, Stamler, JS, Jaraki, O, Scharfstein, J, Vita, JA, and Loscalzo, J, NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties, J. Clin. Invest., 91:1582-1589, 1993.
62. Klandorf, H, Rathore, DS, Iqbal, M, Shi, X, and Van Dyke, K, Accelerated tissue aging and increased oxidative stress in broiler chickens fed allopurinol, Comp. Biochem. Physiol. C. Toxicol. Pharmacol., 129:93-104, 2001.
63. Kosugi, H, Kojima, T, and Kikugawa, K, Characteristics of the thiobarbituric acid reactivity of human urine as a possible consequence of lipid peroxidation, Lipids, 28:337-343, 1993.
64. Laybutt, DR, Kaneto, H, Hasenkamp, W, Grey, S, Jonas, JC, Sgroi, DC, Groff, A, Ferran, C, Bonner-Weir, S, Sharma, A, and Weir, GC, Increased expression of antioxidant and antiapoptotic genes in islets that may contribute to β-cell survival during chronic hyperglycemia, Diabetes, 51:413-423, 2002.
65. Low, PA, Caskey, PE, Tuck, RR, Fealey, RD, and Dyck, PJ, Quantitative sudomotor axon reflex test in normal and neuropathic subjects, Ann. Neurol., 14:573-580, 1983.
66. Low, PA, Nickander, KK, and Tritschler, HJ, The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy, Diabetes, 46(Suppl. 2):S38-42, 1997.
67. Marfella, R, Quagliaro, L, Nappo, F, Ceriello, A, and Giugliano, D, Acute hyperglycemia induces an oxidative stress in healthy subjects, J. Clin. Invest., 108:635-636, 2001.
68. Marfella, R, Verrazzo, G, Acampora, R, La Marca, C, Giunta, R, Lucarelli, C, Paolisso, G, Ceriello, and A, Giugliano, D, Glutathione reverses systemic hemodynamic changes induced by acute hyperglycemia in healthy subjects, Am. J. Physiol., 268:E1167-E1173, 1995.
69. Marner, B, Agner, T, Binder, C, Lernmark, A, Nerup, J, Mandrup-Poulsen, T, and Walldorff, S, Increased reduction of fasting C peptide is associated with islet cell antibodies in type 1 (insulin dependent) diabetic patients, Diabetologia, 28:875-880, 1984.
70. Marnett, LJ, Wright, TL, Crews, BC, Tannenbaum, SR, and Morrow, JD, Regulation of prostaglandin biosynthesis by nitric oxide is revealed by targeted deletion of inducible nitric-oxide synthase, J. Biol. Chem., 275:13427-13430, 2000.
71. Marra, G, Cotroneo, P, Pitocco, D, Manto, A, Di Leo, MAS, Ruotolo, V, Caputo, S, Giardina, B, Ghirlanda, G, and Santini, SA, Early increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated Type 1 diabetes, Diabet., Care, 25:370-375, 2002.
72. Matsuoka, T, Kajimot, Y, Watada, H, Kaneto, H, Kishimoto, M, Umayahara, Y, Fujitani, Y, Kamada, T, Kawamori, R, and Yamasaki, Y, Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells, J. Clin. Invest., 99:144-150, 1997.
73. McIntyre, M, Bohr, DF, and Dominiczak, AF, Endothelial function in hypertension. The role of superoxide anion, Hypertension, 34:539-545, 1999.
74. Ming-Chia, H, Chin-Han, W, Chia-Lin, C, Hung-Chun, C, Chun-Chang, C, and Shyi-Jang, S, High blood glucose and osmolality, but not high urinary glucose and osmolality, affect neuronal nitric oxide synthase expression in diabetic rat kidney, J. Lab. Clin. Med., 151:200-209, 2003.
75. Morrow, JD, Hill, KE, Burk, RF, Nammour, TM, Badr, KF, and Roberts, LJ, A series of prostaglandin F2-like compounds are produced in vivo in humans by a noncyclooxygenase, free radical-catalyzed mechanism, Proc. Natl. Acad. Sci. U.S.A., 87:9383-9387, 1990.
76. Nishikawa, T, Edelstein, D, and Brownlee, M, The missing link: A single unifying mechanism for diabetic complications, Kidney Int., 58(Suppl. 77):S26-S30, 2000.
77. O’Byrne, S, Forte, P, Roberts, LJ, II Morrow, JD, Johnston, A, Anggard, E, Leslie, RDG, and Benjamin, N, Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion, Diabetes, 49:857-862, 2000.
78. Packer, L, Tritschler, JH, and Wessel, K, Neuroprotection by the metabolic antioxidant alpha-lipoic acid, Free Radic. Biol. Med., 22:359-378, 1997.
79. Peuchant, E, Delmas-Beauvieux, MC, Couchouron, A, Dubourg, L, Thomas, MJ, Perromat, A, Clerc, M, and Gin, H, Short-term insulin therapy and normoglycemia. Effects on erythrocyte lipid peroxidation in NIDDM patients, Diabet. Care, 20:202-207, 1997.
80. Pileggi, A, Molano, RD, Berney, T, Cattan, P, Vizzardelli, C, Oliver, R, Fraker, C, Ricordi, C, Pastori, RL, Bach, FH, and Inverardi, L, Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation, Diabetes, 50:1983-1991, 2001.
81. Pitre, DA, Seifert, JL, and Bauer, JA, Perineurium inflammation and altered connexin isoform expression in a rat model of diabetes related peripheral neuropathy, Neurosci. Lett., 303:67-71, 2001.
82. Rabinovitch, A, Suarez, WL, Thomas, PD, Strynadka, K, and Simpson, I, Cytotoxic effects of cytokines on rat islets: evidence for involvement of free radicals and lipid peroxidation, Diabetologia, 35:409-413, 1992.
83. Rassaf, T, Kleinbongard, P, Preik, M, Dejam, A, Gharini, P, Lauer, T, Erckenbrecht, J, Duschin, A, Schulz, R, Heusch, G, Feelisch, M, and Kelm, M, Plasma nitrosothiols contribute to the systemic vasodilator effects of intravenously applied NO, Circulat. Res., 91:470-478, 2002.
84. Saenz de Tejada, I, Goldstein, I, Azadzoi, K, Krane, RJ, and Cohen, RA, Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence, N. Engl. J. Med., 320:1025-1030, 1989.
85. Sagara, M, Satoh, J, Wada, R, Yagihashi, S, Takahashi, K, Fukuzawa, M, Muto, G, Muto, Y, and Toyota, T, Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine, Diabetologica, 39:263-269, 1996.
86. Santos, CXC, Anjos, EI, and Augusto, O, Uric acid oxidation by peroxynitrite: multiple reactions, free radical formation, and amplification of lipid oxidation, Arch. Biochem. Biophy., 372:285-294, 1999.
87. Schmeichel, AM, Schmelzer, JD, and Low, PA, Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy, Diabetes, 52:165-171, 2003.
88. Shishehbor, MH, Aviles, RJ, Brennan, ML, Fu, X, Goormastic, M, Pearce, GL, Gokce, N, Keaney, JF, Jr., Penn, MS, Sprecher, DL, Vita, JA, and Hazen, SL, Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy, JAMA, 289:1675-1680, 2003.
89. Snedecor, GW and Cochran, WG, Statistical Methods, 6th ed., Ames, Iowa University Press, Iowa, p. 172-195, 1967.
90. Sodum, RS, Akerkar, SA, and Fiala, ES, Determination of 3-Nitrotyrosine by highpressure liquid chromatography with a dual-mode electrochemical detector, Anal. Biochem., 280:278-285, 2000.
91. Suto, T, Losonczy, G, Qiu, C, Hill, C, Samsell, L, Ruby, J, Charon, N, Venuto, R, and Baylis, C, Acute changes in urinary excretion of nitrite +nitrate do not necessarily predict renal vascular NO production, Kidney Int., 48:1272-1277, 1995.
92. Takamura, T, Kato, I, Kimura, N, Nakazawa, T, Yonekura, H, Takasawa, S, and Okamoto, H, Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic beta cells develop insulin-dependent diabetes without insulitis, J. Biol. Chem., 273:2493-2496, 1998.
93. Tanaka, Y, Gleason, CE, Tran, POT, Harmon, JS, and Robertson, RP, Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants, Proc. Natl. Acad. Sci., 96:10857-10862, 1999.
94. The Diabetes Control and Complications Trial Research Group, Effect of intensive therapy on residual β-cell function in patients with type 1 diabetes in the Diabetes Control and Complications Trial, Ann. Intern. Med., 128:517-52363, 1998.
95. The Sydney Trial, The sensory symptoms of diabetic polyneuropathy are improved with α-lipoic acid, Diabet. Care, 26:770-776, 2003.
96. Ting, HH, Timimi, FK, Boles, KS, Creager, SJ, Ganz, P, and Creager, MA, Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus, J. Clin. Invest., 97:22-28, 1996.
97. Van Dam, PS, Bravenboer, B, van Asbeck, BS, Marx, JJ, and Gispen, WH, High rat food vitamin E content improves nerve function in streptozotocin-diabetic rats, Eur. J. Pharmacol., 376:217-222, 1999.
98. Vessby, J, Basu, S, Mohsen, R, Berne, C, and Vessby, B, Oxidative stress and antioxidant status in type 1 diabetes mellitus, J. Intern. Med., 251:69-76, 2002.
99. Vinik, AI, Erbas, T, Park, TS, Stansberry, KB, Scanelli, JA, and Pittenger, GL, Dermal neurovascular dysfunction in type 2 diabetes, Diabet. Care, 24:1468-1475, 2001.
100. Xia, Y, Tsai, AL, Berka, V, and Zweier, JL, Superoxide generation from endothelial nitric-oxide synthase, J. Biol. Chem., 273:25804-25808, 1998.
101. Yki-Jarvinen, H, Glucose toxicity, Endocrine Rev., 13:415-431, 1992.
102. Ziegler, D, Hanefeld, M, Ruhnau, KJ, Hasche, H, Lobisch, M, Schutte, K, Kerum, G, and Malessa, R, Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). Alpha-lipoic acid in diabetic neuropathy, Diabet. Care, 22:1296-1301, 1999.
103. Ziegler, D, Schatz, H, Conrad, E, Gries, FA, Ulrich, H, and Reichel, G, Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trail (DEKAN Study). Deutsche Kardiale Autonome Neuropathie, Diabet. Care, 20:369-373, 1997.